-
EP1133297
European procedure
Extract from the Register of European Patents
EP About this file: EP1133297
| EP1133297 - NOVEL THERAPEUTIC USE OF 1,6-DIMETHYL-8BETA-HYDROXYMETHYL-10ALPHA-METHOXYERGOLINE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 25.06.2004 Database last updated on 19.10.2024 | Most recent event Tooltip | 26.11.2004 | Lapse of the patent in a contracting state | published on 12.01.2005 [2005/02] | Applicant(s) | For all designated states Aventis Pharma S.A. 20, avenue Raymond Aron 92160 Antony / FR | [2001/38] | Inventor(s) | 01 /
DIB, Michel 11 rue Henri Michaux F-75013 Paris / FR | [2001/38] | Representative(s) | Rousseau, Pierick Edouard Aventis Pharma S.A. Direction des Brevets Tri LEO/144 20, avenue Raymond Aron 92165 Antony Cedex / FR | [N/P] |
| Former [2001/38] | Rousseau, Pierrick Edouard Aventis Pharma S.A., 20, avenue Raymond Aron 92165 Antony Cedex / FR | Application number, filing date | 99956110.3 | 22.11.1999 | [2001/38] | WO1999FR02868 | Priority number, date | FR19980014792 | 24.11.1998 Original published format: FR 9814792 | [2001/38] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO0030644 | Date: | 02.06.2000 | Language: | FR | [2000/22] | Type: | A1 Application with search report | No.: | EP1133297 | Date: | 19.09.2001 | Language: | FR | The application published by WIPO in one of the EPO official languages on 02.06.2000 takes the place of the publication of the European patent application. | [2001/38] | Type: | B1 Patent specification | No.: | EP1133297 | Date: | 20.08.2003 | Language: | FR | [2003/34] | Search report(s) | International search report - published on: | EP | 02.06.2000 | Classification | IPC: | A61K31/48, A61P21/00, A61P25/00 | [2001/38] | CPC: |
A61K31/48 (EP,US);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/38] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | NEUE THERAPEUTISCHE VERWENDUNG VON 1,6-DIMETHYL-8BETA-HYDROXYMETHYL-10ALPHA-METHOXYERGOLIN | [2001/38] | English: | NOVEL THERAPEUTIC USE OF 1,6-DIMETHYL-8BETA-HYDROXYMETHYL-10ALPHA-METHOXYERGOLINE | [2001/38] | French: | NOUVELLE APPLICATION THERAPEUTIQUE DE LA 1, 6- DIMETHYL-8BETA-HYDROXYMETHYL -10ALPHA- METHOXYERGOLINE | [2001/38] | Entry into regional phase | 13.06.2001 | National basic fee paid | 13.06.2001 | Designation fee(s) paid | 13.06.2001 | Examination fee paid | Examination procedure | 07.06.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 13.06.2001 | Examination requested [2001/38] | 06.02.2003 | Communication of intention to grant the patent | 16.06.2003 | Fee for grant paid | 16.06.2003 | Fee for publishing/printing paid | Opposition(s) | 24.05.2004 | No opposition filed within time limit [2004/33] | Fees paid | Renewal fee | 28.11.2001 | Renewal fee patent year 03 | 02.12.2002 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 30.11.2003 | [2005/02] | Cited in | International search | [A]BE633438 (SOCIETA FARMACEUTICI ITALIA) [A] 1-3 * page 6, line 1 - line 24; example 8; claim - *; | [A]EP0004664 (CORVI MORA E) [A] 1-3* the whole document *; | [DA]FR2616788 (ARYSEARCH ARYLAN AG [LI]) [DA] 1-3 * abstract * * page 2, paragraph L * * page 5, line 17 - line 35; claim - * |